Literature DB >> 26871198

Extrapyramidal Symptoms as a Result of Risperidone Discontinuation During Combination Therapy with Methylphenidate in a Pediatric Patient.

Carlos A Pérez1, Sean S Garcia2, Regina D Yu3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26871198     DOI： 10.1089/cap.2015.0225

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN： 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  3 in total

1.  Movement disorders and use of risperidone and methylphenidate: a review of case reports and an analysis of the WHO database in pharmacovigilance.

Authors:  Dominik Stämpfli; Stefan Weiler; Andrea M Burden
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-07-03       Impact factor: 4.785

2.  Acute Hyperkinetic Movement Disorders as a Multifactorial Pharmacodynamic Drug Interaction Between Methylphenidate and Risperidone in Children and Adolescents.

Authors:  Mohamed Mohamoud; Qi Chen; David Croteau; Carmen Cheng; Keith Burkhart; Donna A Volpe; Cindy Kortepeter; Dorothy Demczar; Marc Stone
Journal:  J Clin Psychopharmacol       Date:  2022 May-Jun 01       Impact factor: 3.118

3.  Dystonia with MPH/Risperidone Combined Therapy for ADHD.

Authors:  J Gordon Millichap; Michelle M Yee
Journal:  Pediatr Neurol Briefs       Date:  2016-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.